Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease
- Conditions
- Parkinson's Disease
- Interventions
- Other: Physical ExerciseOther: Neurofeedback and Physical Exercise
- Registration Number
- NCT01867827
- Lead Sponsor
- Cardiff University
- Brief Summary
The aim of the study is to train patients with Parkinson's Disease to increase activity in a brain area that is involved in the control of motor functions with the use of a technique called real-time fMRI neurofeedback (NF) along with regular physical exercise. This will be a randomised and controlled clinical trial to evaluate the benefits of a novel treatment. The investigators expect NF training along with physical exercise practise to better improve motor functions compared to physical exercise alone.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- People with Parkinson's Disease
- Hoehn and Yahr stages 1-3 of the disease
- Patients with dementia or significant comorbidity
- those who fail the safety screening to go into an MRI scanner
- those who cannot travel to the University
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Physical Exercise Physical Exercise This group will undergo Physical Exercise intervention on the WiiFit device 3 times a week in the first month and once a week after the first month till the end of the study at 12 weeks. Neurofeedback and Physical Exercise Neurofeedback and Physical Exercise This group will undergo neurofeedback intervention in the fMRI scanner in weeks 1,5 and 12. They will also undergo physical exercise training on WiiFit device once a week after the first month till the end of the study at 12 weeks.
- Primary Outcome Measures
Name Time Method Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS) Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS) in 12 weeks
- Secondary Outcome Measures
Name Time Method Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) in 12 weeks Change from baseline in the 'Actigraph' Change from baseline in the 'Actigraph' at 12 weeks Change from baseline in the 'GaitRite' Change from baseline in the 'GaitRite' at 12 weeks
Trial Locations
- Locations (1)
School of Medicine, Cardiff University
🇬🇧Cardiff, Wales, United Kingdom